Checked.be · Company dossier
https://checked.be/en/c/pharma-insight-afgekort-pi-0865904944 · as of 07-11-2026
Home /
PHARMA INSIGHT
Lifetime
16 annual accounts with figures on one time axis, 20 filings since 2004
Gross margin peak €9.2m (2018)
- not published
Result peak €1.2m (2023)
€1.2m ▲ 3.5%
Equity peak €5.8m (2023)
€5.8m ▲ 25.0%
Debts
€2.3m ▼ 34.3%
Staff peak 162.8 FTE (2022)
141.7 FTE ▼ 13.0%
Board 2 names since 2021
Owners
Documents filings and deeds
08-07-2024 23 days before the deadline
2023financial year
Turnover from €15.2m to €17.0m Staff from 162.8 FTE to 141.7 FTE Equity from €4.6m to €5.8m Debts from €3.5m to €2.3m
Key points from the 2023 annual accounts, the last ones filed
53 days to suppliers
PHARMA INSIGHT pays its suppliers 73 days earlier than in 2022. Customers pay 14 days later.
3.46 was 2.28 in 2022
Short-term debts fell from €3.5m to €2.3m.
20 annual accounts since 2004
April June 31 July October 2005 2010 2015 2020
Four of the last ten came late. The 2016 accounts came latest: 77 days after the end of the period.
No score
Board and ownership GS
Director, Vera Goossens, since 01-08-2021
PI HOLDING 100%equity €8.2m (2023) · deed of 22-05-2024 Board & ownership
Recent changes
17-07-2024
Merger: absorbed by ABYLSEN BELGIUM
General meeting of 27-06-2024 · Gazette deed 22-09-2021
Appointment: Go Sense (director)
Permanent representative: Vera Goossens · General meeting of 01-08-2021 · Gazette deed 20-08-2021
Registered office moved within Ghent
New registered office: Ottergemsesteenweg-Zuid 808 bus B166 te 9000 Gent · Previous registered office: Rijvisschestraat 124, 9052 Gent · Reappointment: Vandelanotte Bedrijfsrevisoren CVBA (statutory auditor) · Board meeting of 07-07-2021 · Gazette deed All 33 events
Official details
Source: KBO
Status
Absorbed by Abylsen Belgium SRL merger by absorption, July 2024 Activity
“De consultancy in de farmaceutische, gezondheids-, informatietechnologie- en engineeringsector” (deed in Dutch) From the articles, 28 activities No NACE code in the KBO yet Financial year end
31 December Peppol
Not found in the Peppol Directory
Company details
Annual accounts 2023
Total assets
€8.1m ▼ 0.6% Filing
Filed on 08-07-2024 Financials Companies linked to PHARMA INSIGHT
Insights on PHARMA INSIGHT
Absorbed by Abylsen Belgium SRL in July 2024. The last annual accounts are for financial year 2023.
Key facts about PHARMA INSIGHT
What is the company number of PHARMA INSIGHT?
The company number of PHARMA INSIGHT is 0865.904.944. The VAT number is the same number with BE in front: BE 0865.904.944.
What is the legal form of PHARMA INSIGHT?
Legal form of PHARMA INSIGHT: BV. Is PHARMA INSIGHT still active?
No. PHARMA INSIGHT is inactive in the KBO register.Company details How many employees did PHARMA INSIGHT have?
PHARMA INSIGHT had an average of 141.7 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of PHARMA INSIGHT?
The turnover of PHARMA INSIGHT was €17.0m in financial year 2023, according to the filed annual accounts.
Is PHARMA INSIGHT profitable?
In financial year 2023, PHARMA INSIGHT made a profit of €1.2m.
Where can I find the annual accounts of PHARMA INSIGHT?
PHARMA INSIGHT filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2023.